Market Research Report
Asia Pacific Holter ECG Monitoring Market (2018 - 2024)
|Published by||KBV Research||Product code||763747|
|Published||Content info||82 Pages
Delivery time: 1-2 business days
|Asia Pacific Holter ECG Monitoring Market (2018 - 2024)|
|Published: December 20, 2018||Content info: 82 Pages||
The Asia Pacific Holter ECG Monitoring Market would witness market growth of 10.3% CAGR during the forecast period (2018 - 2024). A holter monitor is a compact-sized wearable device which is used in continuously monitoring or tracking hearts activity. Patients with cardiovascular diseases are recommended holter ECG test. The patient wears the holter monitoring devices for a day or two, and accordingly, the hearts activities are monitored. Heartbeats are monitored throughout the period when various activates are conducted. Asia-Pacific would witness highest growth rate throughout the forecast period, as it has a region with opportunities for the widespread adoption of holter ECG monitoring systems. Significant population base, increasing disposable income, and improvement in patient awareness towards preventive care of cardiovascular diseases are the factors driving the market growth in the Asia Pacific region.
Based on Component, the market is segmented into Wired Holter Monitor, Wireless Holter Monitor and Holter Analysis System & Software. Based on Lead Type, the market is segmented into Single Lead Holter Monitor, 3 Lead Holter Monitor, 6 Lead Holter Monitor, 12 Lead Holter Monitor and Other Lead Holter Monitor. Based on End User, the market is segmented into Hospitals and Clinics, Home setting & Ambulatory Surgical Center and Other End user. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Schiller AG, Mindray Medical International Limited, BPL Medical Technologies, Koninklijke Philips N.V, Nihon Kohden Corporation, Medtronic Plc, Cardiac Science, Fukuda Denshi Co Ltd., GE Healthcare and Welch Allyn.